Crunchbase News recently spoke with Kyle Pretsch, a general partner at Bambu Ventures, about the firm's unique gambit of agreeing to buy telemedicine platform Lemonaid Health from now-bankrupt 23andMe ...
Pharmaceutical Market, Artificial Intelligence, Personalized Medicine, Digital Transformation, Supply Chains, Regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback